SecBot SecBot
Institutional Cluster

APGE

Apogee Therapeutics, Inc.
MIXED
Impact 5/10
Horizonweeks Processed3mo ago
Institutional cluster: 4 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The Citigroup mega-buy ($37.2M increase) is a high-conviction signal from a sophisticated active manager, but it is offset by two near-full exits from Jennison ($48.3M) and Pictet ($21.1M) plus a full exit from Aberdeen ($12.1M). The lack of insider buying weakens the bullish thesis. Monitor upcoming pipeline catalysts and Q3 13F filings to see whether Citigroup's conviction was prescient or the sellers were right to reduce.

DirectionMixed
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$134.49
T+0 close · Aug 6, 2026 · via day close
Latest settled
+0.43%
T+20 · $135.07
Vs SPY
−0.17%
α at T+20
Next horizon
T+60
due 18d ago
  1. T+0 · Aug 6 $134.49entry
  2. T+1 · 3mo ago +0.26%α −0.35% · $134.84
  3. T+5 · 3mo ago −0.03%α −1.24% · $134.45
  4. T+20 · 3mo ago +0.43%α −0.17% · $135.07
  5. T+60 · due 18d ago Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Apogee Therapeutics (APGE) saw a mixed institutional cluster in Q2 2026: 4 buyers added $42.8M in new holdings (led by Citigroup's massive $37.2M increase), while 5 sellers reduced positions by $94.4M (led by Jennison Associates' $48.3M near-exit and Aberdeen Group's full $12.1M exit). The divergence is stark, Citigroup's conviction buy (nearly 20x position) contrasts with two major asset managers exiting almost entirely. The cluster is dominated by active managers on both sides, suggesting a fundamental disagreement on valuation or pipeline prospects rather than passive rebalancing. With no insider buying to corroborate the accumulation side, the net signal is ambiguous despite the large dollar amounts involved.

Key Financial Metrics

Direction
mixed
Buy Value
$48.4M
Sell Value
$94.4M
Net Flow
-$51.6M

Institutional Positions

Net institutional flow: -$51.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
CitigroupDOUBLED+1969.4%$38.4M$37.2M
Alps AdvisorsADD+37.2%$8.3M$4.5M
Strs OhioADD+93.2%$1.1M$758.0K
Envestnet Asset ManagementADD+28.6%$597.0K$303.0K

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Jennison AssociatesNEAR_EXIT-98.8%$49.2M-$48.3M
Pictet Asset Management HoldingNEAR_EXIT-97.5%$22.0M-$21.1M
Td Asset ManagementNEAR_EXIT-88.9%$15.6M-$12.8M
Aberdeen GroupEXIT-100%$12.1M-$12.1M
New York State Common Retirement FundTRIM-38.8%$2.2M-$77.3K

Key Facts

  • 4 institutional buyers added $42.8M in new APGE holdings in Q2 2026
  • 5 institutional sellers reduced positions by $94.4M in the same quarter
  • Citigroup DOUBLED its position by 1,969% to $38.4M, the largest single move
  • Jennison Associates NEAR-EXITED, selling 98.8% of its $49.2M stake
  • Aberdeen Group fully EXITED a $12.1M position
  • No open-market insider buying to support the accumulation side
  • Net institutional flow was negative: $94.4M sold vs $42.8M bought

Financial Impact

4 institutional buyers added $42.8M in new positions while 5 sellers reduced holdings by $94.4M, for a net institutional outflow of approximately $51.6M

institutional ownershipfloat

Risk Factors

  • The 45-day 13F reporting lag means positions may have already been unwound or added to since quarter-end
  • Net institutional outflow of ~$51.6M suggests more capital exited than entered
  • No insider buying to corroborate the accumulation thesis
  • Two major asset managers (Jennison, Pictet) nearly fully exited, signaling potential fundamental concerns

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
33% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-APGE-2026-Q2

Track record

31 reports on APGE

Performance horizon

9 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +73.31% at T+60 after the May 27, 2026 report. 12 of 13 went positive at some point.

Filters
  1. Sep 14, 20269w ago 15-12G Neutral 4/10 No price data
  2. Sep 3, 202610w ago 25-NSE Bullish 8/10 Entry $135.06 No price data
  3. Sep 3, 202610w ago 8-K Bullish 8/10 Entry $135.06 No price data
  4. Aug 11, 202613w ago 8-K Bullish 7/10 Entry $134.55 No price data
  5. Aug 10, 202614w ago 8-K Bullish 8/10 No price data
  6. Aug 10, 202614w ago Press Release Bullish 8/10 Entry $134.65 No price data
  7. Aug 6, 202614w ago Institutional Cluster Mixed 5/10 Viewing Entry $134.49 to $135.07 ▲ +0.43% −0.17% vs SPY
  8. Aug 3, 202615w ago DEFA14A Bullish 5/10 Entry $134.19 to $135.08 ▲ +0.66% +1.90% vs SPY
  9. Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $133.82 to $134.65 ▲ +0.62% −2.56% vs SPY
  10. Jun 26, 202620w ago DEFA14A Bullish 6/10 Entry $132.61 to $134.28 ▲ +1.26% +1.54% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens Wed (10h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026